Complex Discovery

OCTOBER 19, 2024

Editor’s Note: Artificial intelligence (AI) is transforming the pharmaceutical industry, offering unprecedented opportunities to accelerate drug discovery, streamline clinical trials, and fortify intellectual property (IP) strategies.

Pharmaceuticals 111

Pharmaceuticals Discovery Government and Public Sector Chain Of Custody 111

IP Watchdog

JUNE 21, 2022

Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Accord Healthcare, Inc. Earlier today, the U.S. granting a petition for rehearing from appellant HEC Pharm Co.,

Expert Testimony 59

Expert Testimony Pharmaceuticals Healthcare Evidence 59

Complex Discovery

APRIL 18, 2025

This article offers a compelling overview of how blockchain is being adopted, its challenges, and what it means for the future of digital evidence and data security. Healthcare is another field where blockchain is making significant inroads.

Government and Public Sector 52

Government and Public Sector Chain Of Custody Digital Evidence Evidence 52

Complex Discovery

NOVEMBER 3, 2024

As October 2024 concluded, it continues to be evident that the eDiscovery, cybersecurity, and information governance sectors are undergoing significant transformations. As AI becomes a critical tool in pharmaceutical innovation, it also presents challenges around data security, governance, and legal accountability. Read the update.

Government and Public Sector 69

Government and Public Sector Technology Cross-Examination Energy and Utilities 69